Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEXRAZOXANE for Infusion site extravasation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 69 adverse event reports in the FDA FAERS database where DEXRAZOXANE was used for Infusion site extravasation.

Most Reported Side Effects for DEXRAZOXANE

Side Effect Reports % Deaths Hosp.
Febrile neutropenia 315 27.8% 18 274
Off label use 266 23.4% 13 51
Clostridium difficile colitis 91 8.0% 7 90
Cellulitis 84 7.4% 6 81
Product use in unapproved indication 84 7.4% 17 75
Pyrexia 81 7.1% 1 70
Fungal infection 74 6.5% 6 74
Bacterial infection 73 6.4% 6 73
Lymphoid tissue hypoplasia 72 6.3% 6 72
Lymphopenia 70 6.2% 6 70
Thymus hypoplasia 70 6.2% 6 70
Disseminated aspergillosis 67 5.9% 6 67
Cytomegalovirus viraemia 65 5.7% 6 65
Neutropenia 59 5.2% 3 35
Bone marrow failure 55 4.9% 4 25

Other Indications for DEXRAZOXANE

Acute lymphocytic leukaemia (211) Chemotherapy cardiotoxicity attenuation (143) Product used for unknown indication (87) Cardiovascular event prophylaxis (38) Chemotherapy (29) Ewing's sarcoma (29) Osteosarcoma (24) Acute myeloid leukaemia (23) Prophylaxis (22) Soft tissue sarcoma (21)

Related Pages

DEXRAZOXANE Full Profile All Infusion site extravasation Drugs DEXRAZOXANE Demographics DEXRAZOXANE Timeline